Hunting Hill Global Capital »

Revance Therapeutics shares owned by Hunting Hill Global Capital

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Hunting Hill Global Capital from 13F filings

Historical chart of Hunting Hill Global Capital investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Hunting Hill Global Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Hunting Hill Global Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.0M 91k 11.47

More positions owned by Hunting Hill Global Capital

Activision Blizzard Call Option
Horizon Therapeutics Pub L SHS Put Option
Ishares Tr Iboxx Hi Yd Etf (HYG)
Fox Corp Cl B Com (FOX)
Liberty Broadband Corp Com Ser C (LBRDK)
Sprott Physical Gold & Silve Tr Unit (CEF)
Silicon Motion Technology Sponsored Adr Put Option (SIMO)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
First Tr Dynamic Europe Equi Com Shs
Alphabet Cap Stk Cl A (GOOGL)
Seagen Put Option
Ishares Silver Tr Ishares (SLV)
National Instruments
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Dell Technologies CL C (DELL)

View all positions for Hunting Hill Global Capital

Top funds holding Revance Therapeutics

Palo Alto Investors
Vanguard Group
Franklin Resources
Jpmorgan Chase & Co
Jennison Associates
Bamco
Walleye Trading Advisors
Goldman Sachs Group
Rice Hall James & Associates
Charles Schwab Investment Management
Citadel Advisors
Wellington Management Company
D. E. Shaw & Co
HighTower Advisors
Balyasny Asset Management

View all funds holding Revance Therapeutics